Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Cannabis Suisse (CSUI) Cost of Revenue (2016 - 2025)

Cannabis Suisse (CSUI) has disclosed Cost of Revenue for 9 consecutive years, with $7356.0 as the latest value for Q1 2025.

  • On a quarterly basis, Cost of Revenue rose 6.98% to $7356.0 in Q1 2025 year-over-year; TTM through Nov 2025 was $7356.0, a 76.29% decrease, with the full-year FY2025 number at $22068.0, down 26.6% from a year prior.
  • Cost of Revenue was $7356.0 for Q1 2025 at Cannabis Suisse, roughly flat from $7356.0 in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $9442.0 in Q2 2024 to a low of -$1734.0 in Q1 2022.
  • A 5-year average of $5755.9 and a median of $6875.5 in 2023 define the central range for Cost of Revenue.
  • Peak YoY movement for Cost of Revenue: crashed 73.06% in 2021, then surged 296.42% in 2023.
  • Cannabis Suisse's Cost of Revenue stood at $7770.0 in 2021, then crashed by 77.68% to $1734.0 in 2022, then soared by 296.42% to $6874.0 in 2023, then increased by 7.01% to $7356.0 in 2024, then changed by 0.0% to $7356.0 in 2025.
  • Per Business Quant, the three most recent readings for CSUI's Cost of Revenue are $7356.0 (Q1 2025), $7356.0 (Q4 2024), and $7356.0 (Q3 2024).